Cognizant risk/reward remains attractive. says RW Baird Baird said the risk/reward for Cognizant remains attractive citing improving IT trends and upside potential for estimates, a clean balance sheet, and favorable foreign exchange trends. Shares are Outperform rated with a $116 price target.
Cognizant acquisition strategically compelling but expensive, says Bernstein After Cognizant announced plans to buy healthcare services company TriZetto, Bernstein thinks the deal is strategically compelling but expensive. The firm believes that the deal improves Cognizant's competitive position in the IT services market. It reiterates a $61 price target and Outperform rating on Cognizant.